Natalie Dakers is a leading figure in the Canadian health sciences sector. Natalie has been the founding CEO of several high impact and first-of-its kind organizations including Accel-Rx Health Sciences Accelerator, the Centre for Drug Research and Development (CDRD) now Admare BioInnovations, and the commercial arm of CDRD, CDRD Ventures. She co-founded Neuromed Pharmaceuticals, a biotechnology company in the neurological space developing drugs for chronic pain and epilepsy. Early in her career she supported the technology transfer for over a dozen start-ups while at UBC’s Industry Liaison Office. Ms. Dakers has served on many public and private boards, and currently serves on Augurex, BioTalent Canada, Sonic Incytes, Stemcell Technologies, and is an Adjunct Professor at UBC’s Faculty of Pharmaceutical Sciences. Among her many awards are LifeSciences BC Milton Wong Award for Leadership 2019, Startup Canada’s Entrepreneur of the Year 2015, WXN’s Top 100 Most Powerful Women and Business in Vancouver’s Most Influential Woman 2016, 2018 and Industry Leadership BIOTECanada 2009.